BISACODYL TABLETS 5MG 5 MG
BISACODYL : 5 MG · DIN 02243838 · VITA HEALTH PRODUCTS INC
Health Canada status: MARKETED
What is BISACODYL TABLETS 5MG?
BISACODYL TABLETS 5MG 5 MG contains BISACODYL : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02243838, held by VITA HEALTH PRODUCTS INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 01-Apr-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02243838 |
|---|---|
| Brand name | BISACODYL TABLETS 5MG |
| Generic / active ingredient | BISACODYL : 5 MG |
| Manufacturer | VITA HEALTH PRODUCTS INC |
| Strength | 5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AB02 BISACODYL |
| AHFS class | 84:80.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 01-Apr-2003 |
| Original market date | 2002-01-09 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A06AB02 BISACODYL. 16 of 59 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AMB-BISACODYL | 10 MG | SUPPOSITORY | AMBICARE PHARMACEUTICALS INC. | MARKETED | DIN 02520478 |
| BISACODYL LAXATIVE | 5 MG | TABLET | JUNO OTC INC | MARKETED | DIN 02499126 |
| BISACODYL SUPPOSITORY | 10 MG | SUPPOSITORY | ANGITA PHARMA INC. | MARKETED | DIN 02489090 |
| BISACODYL SUPPOSITORY | 10 MG | SUPPOSITORY | JAMP PHARMA CORPORATION | MARKETED | DIN 02361450 |
| BISACODYL TABLETS | 5 MG | TABLET | SIGMA LIFE SCIENCES INC. | MARKETED | DIN 02417413 |
| BISACODYL TABLETS, 5 MG | 5 MG | TABLET | TIME-CAP LABORATORIES, INC | MARKETED | DIN 02550997 |
| BISACODYL-ODAN | 5 MG | TABLET (DELAYED-RELEASE) | ODAN LABORATORIES LTD | MARKETED | DIN 02273411 |
| CARTER'S LITTLE PILLS | 5 MG | TABLET | CHURCH & DWIGHT CANADA CORP | MARKETED | DIN 02219190 |
| CODULAX TABLETS | 5 MG | TABLET | SIGMA LIFE SCIENCES INC. | MARKETED | DIN 02238155 |
| DULCOLAX | 10 MG | SUPPOSITORY | SANOFI CONSUMER HEALTH INC | MARKETED | DIN 00003875 |
Who else supplies BISACODYL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BISACODYL appears in 54 registered pack listings across 7 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.